Discovery & Development
What makes us unique?
CRT offers both discovery and early clinical development capability.
Find out more ›
Scientists & Inventors
Do you have an idea?
CRT has more than 20 years experience in developing and commercialising technology.
Find out more ›
Institutes & Charities
Looking for a partner?
Personalised services to reflect your requirements and progress your research.
Find out more ›
Research Tools
For further information about antibodies, mouse models and cell lines from CRT or to discuss sales or licensing options, please contact us:
Call +44 (0) 20 3469 6300 Email reagents@cancertechnology.com Please read our disclaimer information View Research toolsSubscribe to our newsletter
Licensing Portfolio
Cancer Research Technology has an impressive range of over 200 oncology-focused projects under development and potentially available for licensing.
Search Licensing Portfolio
Featured Opportunities
News
The £50m CRT Pioneer Fund Announces First Investment To Develop Cancer Drugs
The Cancer Research Technology Pioneer Fund (CPF) today has made its first investment in a collaboration with the Cancer Research UK Cancer Therapeutics Unit at The Institute of Cancer Research, London, to develop a promising class of drugs called MPS1 inhibitors to treat cancer. Read more ›